Filing Details

Accession Number:
0001209191-22-052218
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-04 16:19:28
Reporting Period:
2022-09-30
Accepted Time:
2022-10-04 16:19:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600847 Gamida Cell Ltd. GMDA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1947032 L. Abigail Jenkins C/O Gamida Cell Ltd.
116 Huntington Avenue
Boston MA 02116
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-09-30 16,129 $1.55 266,129 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022.